Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors (original) (raw)

Prognostic Significance of Epidermal Growth Factor Receptor (Egfr) in Head and Neck Tumours at Some Selected Hospital in Ghana

Roland Osei Saahene

Research Square (Research Square), 2019

View PDFchevron_right

Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas

Olivier Dassonville, François Demard

Head & Neck, 1991

View PDFchevron_right

Evaluation of EGFR as a prognostic and diagnostic marker for head and neck squamous cell carcinoma patients

Zuzana Horakova

Oncology letters, 2016

View PDFchevron_right

EGFR scoring in head and neck squamous cell carcinoma and its association with clinicopathological variables

smriti rathore

International Journal of Medical Research and Review, 2017

View PDFchevron_right

Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression

Gioacchino Giugliano

Medical oncology (Northwood, London, England), 2017

View PDFchevron_right

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

Raymond Chai

Clinical Cancer Research, 2012

View PDFchevron_right

EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy

Elvio Russi

Anticancer research, 2010

View PDFchevron_right

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

Balazs Hegedus

Oral Oncology, 2011

View PDFchevron_right

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications

Mahmut Ozsahin

Radiation oncology (London, England), 2006

View PDFchevron_right

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

Jesper Eriksen

International Journal of Radiation Oncology*Biology*Physics, 2004

View PDFchevron_right

Analysis of the Epidermal Growth Factor Receptor Gene in Fresh Human Head and Neck Tumors

Avraham Eisbruch

Cancer Research, 1987

View PDFchevron_right

Expression of EGFR and p53 in Head and Neck Tumors among Sudanese Patients

Hussain Gadelkarim

Asian Pacific Journal of Cancer Prevention, 2013

View PDFchevron_right

Epidermal Growth Factor Receptor Protein Detection in Head and Neck Cancer Patients: A Many-Faceted Picture

Rene-Jean Bensadoun

Clinical Cancer Research, 2012

View PDFchevron_right

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma

Giovanni Storto, Alba Fiorentino

Radiation Oncology, 2012

View PDFchevron_right

Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis

Barbara Burtness

Clinical Cancer Research, 2005

View PDFchevron_right

Study of EGFR mutations in head and neck squamous cell carcinomas

Marcio Ricardo Salla

Autopsy Case Reports, 2021

View PDFchevron_right

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma

Yogesh Vashist

Journal of Oral Pathology & Medicine, 2013

View PDFchevron_right

Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas

Luigi Tornillo

Human pathology, 2008

View PDFchevron_right

Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma

Esra Gunduz

Cancer Science, 2008

View PDFchevron_right

Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma

Daniel Ng

Human pathology, 2008

View PDFchevron_right

Integrating Epidermal Growth Factor Receptor Assay With Clinical Parameters Improves Risk Classification for Relapse and Survival in Head-and-Neck Squamous Cell Carcinoma

Andy Trotti

International Journal of Radiation Oncology*Biology*Physics, 2011

View PDFchevron_right

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

Pierre Hainaut

Biomarkers, 2014

View PDFchevron_right

Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma

Luiz Kowalski

Sao Paulo Medical Journal, 2004

View PDFchevron_right

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck

Andre Eckardt

British Journal of Cancer, 2007

View PDFchevron_right

Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck

Peter Sacks

Cancer research, 1989

View PDFchevron_right